MLPH   $0.0004  33.33% Market Closed

Molecular Pharmacology USA Ltd
Total Cash 1.52K
totalCashPerShare 0.0
EBITDA -98.11K
Total Debt 2.08M
quickRatio 0.276
currentRatio 0.276
Total Revenue
debtToEquity
Revenue/Share
ROA -5.69414
ROE
grossProfits
freeCashflow -65.61K
operatingCashflow -109.35K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.09M
forwardPE
floatShares
sharesOutstanding 999.55M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.019
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -105.18K
trailingEps 0.0
forwardEps
enterpriseToEbitda -21.26
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount
lastUpdated Oct. 16, 2024, 5:37 p.m.